Semiconductor stocks have been all the rage due to the rising demand driven by artificial intelligence. In the midst of this frenzy, Axcelis Technologies (NASDAQ: ACLS) has been a laggard with its shares taking a 15% dip over the past year.
But is this under-the-radar company merely an overlooked gem, or is there a deeper underlying concern?
Unraveling Axcelis’s Semiconductor Contribution
Axcelis specializes in ion implantation, a crucial process in semiconductor manufacturing. This technique involves altering the electrical properties of silicon wafers by exposing them to ions. While not all semiconductors necessitate ion implantation, the market for this process is significant, valued at $2.1 billion and forecasted to reach $3.5 billion by 2030.
Comparatively, the ion implantation segment, where Axcelis operates, is more specialized and smaller. For instance, extreme ultraviolet lithography (EUV) used in premium chip production commands a market exceeding $10 billion. Bearing annual revenue of $1.1 billion and a $3.5 billion market cap, Axcelis’s size mirrors the scope of its market.
Despite escalating semiconductor demand in recent years, Axcelis has witnessed record revenue and earnings per share. However, the subdued long-term prospects for ion implantation indicate that the company might not experience the same growth surge seen in other semiconductor sectors influenced by AI.
Potential Growth at an Accessible Price
Paradoxically, analysts have tempered their enthusiasm for Axcelis, significantly curbing long-term earnings growth projections over the next three to five years. While 13% growth remains respectable, the constrained potential of the ion implantation market restricts the company’s growth ceiling.
Given this scenario, acquiring the company’s stock at an opportune price becomes imperative. Presently, shares are trading at 16 times their estimated 2024 earnings.
Investment Outlook for the Long Haul
Although current figures portray Axcelis as a sound investment, the dilemma of being a significant player in a niche market looms large. This limitation can stifle growth and hinder investment returns. Axcelis’s historical performance, from a boom in the early 2000s to a protracted recovery post-bubble burst, exemplifies this predicament.
The stock’s lackluster performance against the market underscores this trend:
While there is potential for a change in trend, uncertainty clouds the extent of this shift. The company’s stagnation in diversification beyond its core operations raises skepticism. Hence, investors might consider observing from the sidelines and exploring alternatives with more promising growth trajectories.
Should you consider investing $1,000 in Axcelis Technologies at present?
Prior to investing in Axcelis Technologies, it is prudent to weigh the following:
The Motley Fool Stock Advisor analysts have identified what they deem the 10 most promising stocks for current investors – with Axcelis Technologies not making the cut. These chosen stocks have the potential for substantial returns in the forthcoming years.
Stock Advisor provides investors with a clear roadmap for success, offering portfolio construction guidance, regular analyst updates, and two fresh stock recommendations each month. Since 2002, the Stock Advisor service has outperformed the S&P 500 yield thrice over*.
Explore the 10 stocks
*Stock Advisor returns as of March 25, 2024
Justin Pope holds no position in any of the mentioned stocks. The Motley Fool maintains no position in any of the stocks discussed. The Motley Fool abides by a disclosure policy.
The expressed views and opinions are solely those of the author and do not necessarily align with Nasdaq, Inc.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
